Lux Ventures IV, L.P.

Insider Reports History

Location
295 Madison Avenue, 24 Th Floor, New York, NY
Signature
/s/ Peter Hebert, Manager, Lux Ventures IV, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lux Ventures IV, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. Former 10% Owner Class A common stock 13M $138M $10.58 Dec 7, 2021 Direct
Latch, Inc. 10%+ Owner Common Stock 4.08M $4.49M $1.10 Sep 28, 2021 Indirect

Insider Reports Filed by Lux Ventures IV, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RXRX RECURSION PHARMACEUTICALS, INC. Dec 7, 2021 1 $0 4 Dec 9, 2021 Former 10% Owner
LTCH Latch, Inc. Sep 28, 2021 2 $0 4 Oct 5, 2021 10%+ Owner
LTCH Latch, Inc. Jun 4, 2021 0 $0 3 Jun 8, 2021 10%+ Owner